THE VALUE OF SYSTEMIC INFLAMMATORY BIOMARKERS IN ASSESSING SEVERITY IN PATIENTS WITH CEREBRAL INFARCTION. YHCĐ 2026, 67 (CĐ11-NCKH). https://doi.org/10.52163/yhc.v67iCD11.6035.